Skip to main content
OpenTrials
Completed

NCT Number: NCT06293859

Effect of 12-week Probiotic Consumption Immobilized on Oat Flakes on Blood and Urine Biomarkers and Human Microbiome

The purpose of this clinical trial was to evaluate the effects Lactococcus cremoris spp. im-mobilized on oat flakes on human microbiome and blood and urine biomarkers of associated with human health.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of the Aegean

Myrina, Limnos/Lesvos, 81 400, Greece

About this study

All eligible and consenting individuals were assigned a unique code for identification purposes. They were then randomly assigned to either the probiotic or placebo group. The probiotic group received oat flakes containing immobilized Lactococcus cremoris, while the placebo group received oat flakes indistinguishable in color, smell, and taste from the flakes with immobilized probiotics.Participants received written instructions on storing the product, which required refrigeration. They were instructed to consume 5 g of oats daily with a meal, ensuring the meal's temperature remained below 35 °C and was non-acidic (e.g., with yogurt). Biological samples were collected at three time points; before intervention, at 6th and 12th week.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • participants to be aged between 18 and 65 years
  • clinically tested with fasting plasma glucose less than 100 mg/dL
  • clinically tested withcholesterol less than 220 mg/dL
  • otherwise healthy

Exclusion criteria

  • body mass index [BMI] higher than 40 kg/m2 (morbidly obese)
  • following a diet plan for weight loss
  • following a contraceptive treatment or taking probiotic supplements
  • following medication with an effect on lipaemia or glycemia indicators
  • having any allergies/intolerances to trial ingredients
  • pregnant or planning to become pregnant or breast feeding
  • users of illicit drug, having a chronic alcoholism or total daily alcohol intake more than 50 g per day
  • diagnosed with a chronic condition (cancer, active liver disease, severe kidney dysfunction, severe stroke in the last six months and conditions associated with an increased risk of bleeding) or any other serious medical condition that may affect the individual's ability to participate in a dietary intervention study
  • considered unreliable by the researcher or having a shorter life expectancy than the expected duration of the study due to some illness or if they were in any situation in which by the researcher's opinion their participation in the study was not considered safe (e.g. drug addiction, alcohol abuse).

Treatment and study plan

Probiotic oat flakes

Other

2 x 10^9 cfu/g Lactococcus cremoris immobilized on oat flakes

Conventional oat flakes

Other

Commercial oat flakes

Primary outcomes

  1. Inflammatory biomarkers

    Time frame: Blood samples were collected by venipuncture at three time points; before intervention, at 6th and 12th week

    Change from baseline of hs-CRP and IL-6

Sponsors and collaborators

Lead sponsor

University of the Aegean

Other

Collaborators

  • Democritus University of Thrace

Registry information

Official study title

Effect of Daily Lactococcus Cremoris Spp. Consumption Immobilized in Oat Flakes on Blood and Urine Biomarkers and Human Microbiome: a Randomized Placebo-controlled Clinical Trial

Acronym: FOODBIOMES CT2

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
Mar 5, 2024
Registry last updated
Mar 5, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.